Feed/Companies/ADCytherix

ADCytherix

As of 14 Oct 2026, ADCytherix has raised $122.3M across 1 verified round on record (amounts in other currencies converted to USD); latest: €105 million (US$ 122 million) Series A led by Andera Partners, Angelini Ventures and 2 others, announced 16 Oct 2025.

BUILT ON

Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.

adcytherix.comLinkedInMarseille, France

LATEST ROUND

Series A

$122.3M · 2025-10-16

RAISED ON RECORD · USD

$122.3M

across 1 verified round

INVESTORS

4 leads

SOURCES

from 2 publishers

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series A

$122.3M · 2025-10-16

[ HISTORY ]

led by Andera Partners, Angelini Ventures, Bpifrance, Kurma Partners

Round	Amount	Announced	Lead	Buzz
Series A [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$122.3M €105 million (US$ 122 million)	2025-10-16	Andera Partners, Angelini Ventures, Bpifrance, Kurma Partners	No recent discussion
2 sources [ VERIFIED · CORRECTED ] read against 2 sources Lead added Angelini Ventures · adcytherix.com HQ added Marseille, France · globenewswire.com

ADCytherix

Company

Rounds

Sources

Profile

Investors

ADCytherix

Rounds

Profile

Sources

Series A$122.3M2025-10-162 sources

Investors

Series A$122.3M2025-10-1610 investors